Episode

PsA GRAPPA Domains: Outcomes With a JAKi

Podcast
Rheumnow Podcast
Published
Apr 1, 2026
Duration seconds
1086
Processing state
not_requested
Canonical source
https://rheumnow.podbean.com/e/psa-grappa-domains-outcomes-with-a-jaki/
Audio
https://mcdn.podbean.com/mf/web/gr7sri3ttxmip27e/PsA_GRAPPA_Domains-_Outcomes_With_a_JAKib5khw.mp3
JSON
/v1/public/podcasts/rheumnow-podcast-587987/episodes/psa-grappa-domains-outcomes-with-a-jaki
Markdown
/podcast/rheumnow-podcast-587987/psa-grappa-domains-outcomes-with-a-jaki.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/rheumnow-podcast-587987/episodes/psa-grappa-domains-outcomes-with-a-jaki/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/rheumnow-podcast-587987/psa-grappa-domains-outcomes-with-a-jaki.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Schwartzman and Dr. Ruderman discuss how PsA disease activity across GRAPPA domains may guide treatment decisions, sharing both the evidence for and their experience with a JAKi across domains.Sponsored by AbbVie Medical Affairs + Health Impact